Bracket announces the addition of J. Matthew Bond as Chief Financial Officer.

Bracket, a leading clinical trial specialty services provider, today announced the addition of J. Matthew Bond as Chief Financial Officer and as a member of the company’s leadership team.

Matt brings more than 25 years of experience to Bracket, primarily through leadership positions in growth oriented, pharmaceutical outsourcing firms. Most recently, Matt co-founded and served as the CFO of Aptiv Solutions, a mid-size, specialized contract research organization focused on adaptive methods for biopharmaceutical clinical development and in the medical device approval market. During his tenure, he grew the business from its startup phase to a large multi-national organization primarily through a series of strategic acquisitions, and was the recognized leader in the development and execution of adaptive clinical trials until its acquisition in 2014. Previously, Matt was Executive Vice President and CFO of a global, growth oriented CRO, where over 6 years he led a very successful initial public offering and created significant value for the various stakeholders.

“I couldn’t be more thrilled to welcome Matt to Bracket where he will undoubtedly make an immediate impact,” said Jeff Kinell, president and CEO of Bracket. “I am particularly impressed with Matt’s ability to lead a financial function in a complex, industry-leading business, while maintaining an unrelenting focus on serving and advocating for his company’s customers.”

“I can’t imagine a more exciting time to join Bracket,” Mr. Bond said. “Bracket is leading the transformation of eCOA, RTSM and Rater Training. Jeff and the leadership team recognize and appreciate that they’re making history, and I’m delighted to be a part of it.”

“Matt is extremely well qualified to serve as CFO,” said Dave Ament, Managing Partner, Boston office head, Parthenon Capital Partners and lead director of Bracket. “His deep leadership experience will be a strong complement to our leadership team and will be invaluable as we continue to drive our strategic and financial business transformation.”

About Bracket

Bracket, with seven offices and more than 500 employees worldwide, is a specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.